1. Home
  2. EVH vs RCUS Comparison

EVH vs RCUS Comparison

Compare EVH & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVH
  • RCUS
  • Stock Information
  • Founded
  • EVH 2011
  • RCUS 2015
  • Country
  • EVH United States
  • RCUS United States
  • Employees
  • EVH N/A
  • RCUS N/A
  • Industry
  • EVH Other Consumer Services
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVH Consumer Discretionary
  • RCUS Health Care
  • Exchange
  • EVH Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • EVH 1.2B
  • RCUS 1.4B
  • IPO Year
  • EVH 2015
  • RCUS 2018
  • Fundamental
  • Price
  • EVH $10.00
  • RCUS $14.02
  • Analyst Decision
  • EVH Strong Buy
  • RCUS Buy
  • Analyst Count
  • EVH 13
  • RCUS 12
  • Target Price
  • EVH $20.85
  • RCUS $34.50
  • AVG Volume (30 Days)
  • EVH 2.3M
  • RCUS 609.3K
  • Earning Date
  • EVH 02-20-2025
  • RCUS 02-19-2025
  • Dividend Yield
  • EVH N/A
  • RCUS N/A
  • EPS Growth
  • EVH N/A
  • RCUS N/A
  • EPS
  • EVH N/A
  • RCUS N/A
  • Revenue
  • EVH $2,464,254,000.00
  • RCUS $263,000,000.00
  • Revenue This Year
  • EVH $31.68
  • RCUS $127.65
  • Revenue Next Year
  • EVH $14.35
  • RCUS N/A
  • P/E Ratio
  • EVH N/A
  • RCUS N/A
  • Revenue Growth
  • EVH 37.65
  • RCUS 119.17
  • 52 Week Low
  • EVH $9.88
  • RCUS $13.51
  • 52 Week High
  • EVH $35.00
  • RCUS $20.31
  • Technical
  • Relative Strength Index (RSI)
  • EVH 32.51
  • RCUS 37.13
  • Support Level
  • EVH $9.88
  • RCUS $13.81
  • Resistance Level
  • EVH $12.78
  • RCUS $14.52
  • Average True Range (ATR)
  • EVH 0.71
  • RCUS 0.60
  • MACD
  • EVH -0.02
  • RCUS -0.09
  • Stochastic Oscillator
  • EVH 3.71
  • RCUS 22.97

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: